Thyroid Cancer clinical trials in Oregon

5 actively recruiting thyroid cancer trials at 10 sites across Oregon.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does not respond to treatment (refractory) and which expresses a BR…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT06475989

Sites in Oregon:

Saint Alphonsus Cancer Care Center-Baker City — Baker City, Oregon
Saint Alphonsus Cancer Care Center-Ontario — Ontario, Oregon

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two par…

Sponsor: Pfizer

NCT ID: NCT05538130

Sites in Oregon:

Providence Cancer Institute Franz Clinic — Portland, Oregon
Providence Portland Medical Center — Portland, Oregon

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines in people with solid tumors. This study is …

Sponsor: Pfizer

NCT ID: NCT05355701

Sites in Oregon:

Providence Cancer Institute Franz Clinic — Portland, Oregon
Providence Portland Medical Center — Portland, Oregon

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Oregon:

Saint Alphonsus Cancer Care Center-Baker City — Baker City, Oregon
Saint Charles Health System — Bend, Oregon
Clackamas Radiation Oncology Center — Clackamas, Oregon
Providence Cancer Institute Clackamas Clinic — Clackamas, Oregon
Bay Area Hospital — Coos Bay, Oregon

View on ClinicalTrials.gov →

Recruiting Industry

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer types. The cancers included in this study are brain, breast, …

Sponsor: Adela, Inc

NCT ID: NCT05366881

Sites in Oregon:

Oregon Health Sciences University — Portland, Oregon

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20